Kahweol, a Coffee Diterpene with Anti-inflammatory Properties

Coffee in Health and Disease Prevention

Volumn , Issue , 2015, Pages 627-633

  Cárdenas, Casimiro ^a   Quesada, Ana R ^a   Medina, Miguel Á ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Anti inflammatory; Coffee; COX 2; Kahweol; MCP 1; NF B; Nitric oxide; STAT 1

Indexed keywords

EID: 84943327515     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-409517-5.00070-X     Document Type: Chapter

References (36)

1. Spiller M.A. The chemical components of coffee. Prog Clin Biol Res 1984, 158:91-147.
2. Bengis R.O., Anderson R.J. The chemistry of coffee bean. I. Concerning the unsaponifiable matter of the coffee bean oil. Extraction and properties of kahweol. J Biol Chem 1932, 97:99-113.
3. Gross G., Jaccaud E., Huggett A.C. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem Toxicol 1997, 35:547-554.
4. Higdon J.V., Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006, 46:101-123.
5. Heckers H., Göbel U., Kleppel U. End of the coffee mystery: diterpene alcohols raise serum low-density lipoprotein cholesterol and triglyceride levels. J Intern Med 1994, 235:192-193.
6. Weusten-Van der Wouw M.P.M.E., Katan M.B., Viani R., Huggett A.C., Liardon R., Lund-Larsen P.G., et al. Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes. J Lipid Res 1994, 35:721-733.
7. Urgert R., Schulz A.G., Katan M.B. Effects of cafestol and kahweol from coffee grounds on serum lipids and serum liver enzymes in humans. Am J Clin Nutr 1995, 61:149-154.
8. Rustan A.C., Halvorsen B., Huggett A.C., Ranheim T., Drevon C.A. Effect of coffee lipids (cafestol and kahweol) on regulation of cholesterol metabolism in HepG2 cells. Arterioscler Thromb Vasc Biol 1997, 17:2140-2149.
9. Urgert R., Essed N., van der Weg G., Kosmeijer-Schuil T.G., Katan M.B. Separate effects of the coffee diterpenes cafestol and kahweol on serum lipids and liver aminotransferases. Am J Clin Nutr 1997, 65:519-524.
10. Boekschoten M.V., Schouten E.G., Katan M.B. Coffee bean extracts rich and poor in kahweol both give rise to elevation of liver enzymes in healthy volunteers. Nutr J 2004, 3:7.
11. Knowles R.G., Moncada S. Nitric oxide synthases in mammals. Biochem J 1994, 298:249-258.
12. Kim J.Y., Jung K.S., Lee K.J., Na H.K., Chun H.K., Kho Y.H., et al. The coffee diterpene kahweol suppress the inducible nitric oxide synthase expression in macrophages. Cancer Lett 2004, 213:147-154.
13. Kim J.Y., Kim D.H., Jeong H.G. Inhibitory effect of the coffee diterpene kahweol on carrageenan-induced inflammation in rats. Biofactors 2006, 26:17-28.
14. Subbaramaiah K., Dannenberg A.J. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 2003, 24:96-102.
15. Simmons D.L., Botting R.M., Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004, 56:387-437.
16. D'Acquisto F., Iuvone T., Rombola L., Sautebin L., Rosa M.D., Carnuccio R. Involvement of NFκB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett 1997, 418:175-178.
17. Kim J.Y., Jung K.S., Jeong H.G. Suppressive effects of the kahweol and cafestol on cyclooxygenase-2 expression in macrophages. FEBS Lett 2004, 569:321-326.
18. Cárdenas C., Quesada A.R., Medina M.A. Antiangiogenic and anti-inflammatory properties of kahweol, a coffee diterpene. PLoS One 2011, 6:e23407.
19. Iiyama K., Hajra L., Iiyama M., Li H., DiChiara M., Medoff B.D., et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 1999, 85:199-207.
20. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-kappaB activation by tumour necrosis factor requires the AKT serine-threonine kinase. Nature 1999, 401:82-85.
21. Kim H.G., Kim J.Y., Hwang Y.P., Lee K.J., Lee K.Y., Kim D.H., et al. The coffee diterpene kahweol inhibits tumor necrosis factorα-induced expression of cell adhesion molecules in human endothelial cells. Toxicol Appl Pharmacol 2006, 217:332-341.
22. Lam L.K., Sparnins V.L., Wattenberg L.W. Isolation and identification of kahweol palmitate and cafestol palmitate as active constituents of green coffee beans that enhance glutathione S-transferase activity in the mouse. Cancer Res 1982, 42:1193-1198.
23. Huber W.W., Scharf G., Rossmanith W., Prustomersky S., Grasl-Kraupp B., Peter B., et al. The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat. Arch Toxicol 2002, 75:685-694.
24. Huber W.W., Prustomersky S., Delbanco E., Uhl M., Scharf G., Turesky R.J., et al. Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol. Arch Toxicol 2002, 76:209-217.
25. Lee K.J., Choi J.H., Jeong H.G. Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice. Food Chem Toxicol 2007, 45:2118-2125.
26. Lee K.J., Jeong H.G. Protective effects of kahweol and cafestol against hydrogen peroxide-induced oxidative stress and DNA damage. Toxicol Lett 2007, 173:80-87.
27. Shen T., Park Y.C., Kim S.H., Lee J., Cho J.Y. Nuclear factorκB/signal transducers and activators of transcription-1-mediated inflammatory responses in lipopolysaccharide-activated macrophages are a major inhibitory target of kahweol, a coffee diterpene. Biol Pharm Bull 2010, 33:1159-1164.
28. Melgarejo E., Medina M.A., Sanchez-Jimenez F., Botana L.M., Dominguez M., Escribano L., et al. (-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes. Cell Mol Life Sci 2007, 64:2690-2701.
29. Melgarejo E., Medina M.A., Sanchez-Jimenez F., Urdiales J.L. Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro. Br J Pharmacol 2009, 158:1705-1712.
30. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936.
31. Quesada A.R., Muñoz-Chápuli R., Medina M.A. Antiangiogenic drugs: from bench to clinical trials. Med Res Rev 2006, 26:483-530.
32. Quesada A.R., Medina M.A., Alba E. Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer. Bioessays 2007, 29:1159-1168.
33. Quesada A.R., Medina M.A., Muñoz-Chápuli R., Ponce A.L.G. Do not say ever never more: the ins and outs of antiangiogenic therapies. Curr Pharm Des 2010, 16:3932-3957.
34. Futagami S., Hiratsuka T., Shindo T., Hamamoto T., Tatsuguchi A., Nobue U., et al. COX-2 and CCR2 induced by CD40 ligand and MCP-1 are linked to VEGF production in endothelial cells. Prostaglandins Leukot Essent Fatty Acids 2008, 78:137-146.
35. Totzke G., Schulze-Osthoff K., Janicke R.U. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition. Oncogene 2003, 22:8021-8030.
36. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.